X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (92) 92
animals (73) 73
humans (38) 38
pharmacology & pharmacy (31) 31
toxicology (30) 30
venom (30) 30
cobra cardiotoxin proteins - pharmacology (24) 24
mice (22) 22
molecular sequence data (19) 19
amino acid sequence (18) 18
biochemistry & molecular biology (17) 17
cobra cardiotoxin proteins - toxicity (17) 17
elapid venoms - chemistry (15) 15
proteins (15) 15
rats (15) 15
snakes (15) 15
cobra venom (14) 14
elapid venoms - pharmacology (14) 14
female (14) 14
snake-venom (13) 13
toxins (13) 13
elapid venoms - toxicity (12) 12
male (12) 12
snake venom (12) 12
cobra cardiotoxin proteins - chemistry (11) 11
elapidae (11) 11
poisonous snakes (11) 11
analysis (10) 10
cardiotoxin (9) 9
cell line, tumor (9) 9
cells, cultured (9) 9
models, molecular (9) 9
muscle contraction - drug effects (9) 9
phospholipase a (9) 9
cobra cardiotoxin proteins - antagonists & inhibitors (8) 8
cobra cardiotoxin proteins - isolation & purification (8) 8
complex mixtures (8) 8
dose-response relationship, drug (8) 8
elapid venoms - antagonists & inhibitors (8) 8
evolution (8) 8
in vitro techniques (8) 8
nicotinic acetylcholine-receptors (8) 8
protein conformation (8) 8
skeletal-muscle (8) 8
amino-acid-sequence (7) 7
calcium - metabolism (7) 7
expression (7) 7
inflammation (7) 7
medicine (7) 7
neurotoxins - chemistry (7) 7
phospholipases a2 (7) 7
phosphorylation (7) 7
physiology (7) 7
purification (7) 7
antivenom (6) 6
apoptosis - drug effects (6) 6
blotting, western (6) 6
calcium - pharmacology (6) 6
guinea pigs (6) 6
heart - drug effects (6) 6
magnetic resonance spectroscopy (6) 6
mass spectrometry (6) 6
multidisciplinary sciences (6) 6
physiological aspects (6) 6
protein (6) 6
structure-activity relationship (6) 6
alpha-neurotoxin (5) 5
alpha-neurotoxins (5) 5
amino-acid oxidase (5) 5
antineoplastic agents - pharmacology (5) 5
binding (5) 5
binding sites (5) 5
biochemical research methods (5) 5
biological products (5) 5
cell biology (5) 5
cells (5) 5
elapidae - metabolism (5) 5
evolution, molecular (5) 5
hannah king cobra (5) 5
hemolysis - drug effects (5) 5
inhibition (5) 5
molecular evolution (5) 5
muscle, skeletal - drug effects (5) 5
naja kaouthia (5) 5
neurotoxicity (5) 5
neurotoxins (5) 5
neurotoxins - pharmacology (5) 5
peptides (5) 5
pharmacology (5) 5
phylogeny (5) 5
potassium chloride - pharmacology (5) 5
protein structure, secondary (5) 5
proteomics (5) 5
regeneration (5) 5
research (5) 5
snake venoms - chemistry (5) 5
toxicity (5) 5
activation (4) 4
alpha-bungarotoxin (4) 4
amino acids (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Toxicon, ISSN 0041-0101, 06/2015, Volume 99, pp. 23 - 35
The venom proteome of the monocled cobra, , from Thailand, was characterized by RP-HPLC, SDS-PAGE, and MALDI-TOF-TOF analyses, yielding 38 different proteins... 
Monocled cobra | Naja kaouthia | Snake venom: proteomics | Toxicity | Immunity | Human IgG response | BITE | ANTIVENOM DEVELOPMENT | PHAGE DISPLAY | PHOSPHOLIPASE A | ELAPIDAE | SINGLE-DOMAIN ANTIBODIES | SKELETAL-MUSCLE | EVOLUTION | PURIFICATION | PHARMACOLOGY & PHARMACY | THAI COBRA | TOXICOLOGY | Elapid Venoms - chemistry | Immunoglobulin G - isolation & purification | Reptilian Proteins - chemistry | Peptide Fragments - toxicity | Humans | Molecular Sequence Data | Snake Bites - metabolism | Cobra Cardiotoxin Proteins - chemistry | Cobra Cardiotoxin Proteins - antagonists & inhibitors | Thailand | Snake Bites - immunology | Cobra Neurotoxin Proteins - antagonists & inhibitors | Peptide Mapping | Immunoglobulin G - analysis | Snake Bites - blood | Cobra Cardiotoxin Proteins - isolation & purification | Elapidae - immunology | Phospholipases A2 - chemistry | Elapid Venoms - toxicity | Amino Acid Sequence | Antivenins - analysis | Enzyme-Linked Immunosorbent Assay | Cobra Neurotoxin Proteins - isolation & purification | Peptide Fragments - isolation & purification | Cobra Neurotoxin Proteins - toxicity | Cobra Cardiotoxin Proteins - toxicity | Elapid Venoms - antagonists & inhibitors | Lethal Dose 50 | Phospholipases A2 - toxicity | Reptilian Proteins - isolation & purification | Cobra Neurotoxin Proteins - chemistry | Peptide Fragments - chemistry | Animals | Peptide Fragments - antagonists & inhibitors | Elapidae - metabolism | Proteomics | Mice | Reptilian Proteins - toxicity | Reptilian Proteins - antagonists & inhibitors | Phospholipases A2 - isolation & purification | Oxidases | Cysteine | Analysis | Immunoglobulin G | Venom | Nerve growth factor | Investigations | Enzyme-linked immunosorbent assay | Nucleotidases | Index Medicus | Human | Proteins | Adenosines | Nucleosides | Toxins | Snakes | ELISA
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 02/2017, Volume 95, pp. 1022 - 1036
Cardiotoxins (CTXs) are single polypeptide chain consisting of 59–62 amino acids with four disulfide bridges and globular proteins of simple β-sheet folds. The... 
Molecular dynamics | Snake venom | Heterogeneous bilayer | Inhibitors | RBC lysis | STRUCTURAL STABILITY | INDIAN COBRA | POLYMER SCIENCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHOSPHOLIPASE A | PLASMA-MEMBRANE | UNFOLDING STABILITIES | AMINO-ACID-SEQUENCE | BETA-SHEET PROTEIN | WITHANIA-SOMNIFERA | CHEMISTRY, APPLIED | TAIWAN COBRA | CHEMICAL MODIFICATION | Elapid Venoms - chemistry | Hemolysis - drug effects | Small Molecule Libraries - pharmacology | User-Computer Interface | Humans | Imidazoles - chemistry | Structure-Activity Relationship | Cobra Cardiotoxin Proteins - chemistry | Cobra Cardiotoxin Proteins - antagonists & inhibitors | Cholesterol - chemistry | Disulfides - chemistry | Protein Domains | Elapid Venoms - isolation & purification | Cobra Cardiotoxin Proteins - isolation & purification | Antidotes - pharmacology | Elapid Venoms - toxicity | Amino Acid Sequence | Antidotes - chemistry | Protein Structure, Secondary | Phosphatidylserines - chemistry | Cobra Cardiotoxin Proteins - toxicity | Elapid Venoms - antagonists & inhibitors | Imidazoles - pharmacology | Phosphatidylcholines - chemistry | Erythrocyte Membrane - drug effects | Molecular Dynamics Simulation | Small Molecule Libraries - chemistry | Animals | Etidronic Acid - pharmacology | High-Throughput Screening Assays | Diphosphonates - chemistry | Elapidae - metabolism | Erythrocyte Membrane - chemistry | Etidronic Acid - chemistry | Phosphatidylethanolamines - chemistry | Diphosphonates - pharmacology | Venom | Investigations | Index Medicus
Journal Article
Journal Article
Journal Article
Life Sciences, ISSN 0024-3205, 2012, Volume 90, Issue 1, pp. 54 - 65
Journal Article
Toxicon, ISSN 0041-0101, 2010, Volume 56, Issue 4, pp. 508 - 520
Cardiotoxin III (CTX III), a basic polypeptide with 60-amino acid residues isolated from venom, has been reported to have cytotoxic activity. CTX III exerted... 
CTX III | STAT | Akt | Ca9-22 cells | PI3 K | Src | PATHWAYS | NAJA-NAJA-ATRA | HEAD | PROTEIN-TYROSINE KINASES | DOWN-REGULATION | FAMILY | SIGNALING ACTIVATION | GROWTH-FACTOR RECEPTOR | BREAST-CANCER CELLS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | NECK | Elapid Venoms - chemistry | Receptor, Epidermal Growth Factor - genetics | Apoptosis - drug effects | Elapidae | Humans | Transcriptional Activation - drug effects | Cobra Cardiotoxin Proteins - pharmacology | Cobra Cardiotoxin Proteins - chemistry | Proto-Oncogene Proteins pp60(c-src) - physiology | Proto-Oncogene Proteins c-akt - genetics | Proto-Oncogene Proteins c-bcl-2 - metabolism | STAT5 Transcription Factor - genetics | STAT5 Transcription Factor - metabolism | Receptor, Epidermal Growth Factor - metabolism | bcl-Associated Death Protein - metabolism | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Cobra Cardiotoxin Proteins - isolation & purification | STAT3 Transcription Factor - genetics | STAT3 Transcription Factor - metabolism | bcl-Associated Death Protein - genetics | Proto-Oncogene Proteins pp60(c-src) - antagonists & inhibitors | Enzyme Activation - drug effects | X-Linked Inhibitor of Apoptosis Protein - genetics | Carcinoma, Squamous Cell | Mouth Neoplasms | Animals | Proto-Oncogene Proteins pp60(c-src) - metabolism | X-Linked Inhibitor of Apoptosis Protein - metabolism | Cell Line, Tumor | Cell Cycle - drug effects | Proto-Oncogene Proteins c-bcl-2 - genetics | Cytochrome c | Squamous cell carcinoma | Cell cycle | Apoptosis | Index Medicus
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 08/2010, Volume 37, Issue 8, pp. 833 - 840
P>1. Cardiotoxin (CTX) III, a basic polypeptide with 60 amino acid residues isolated from Naja naja atra venom, has potential anticancer therapeutic activity.... 
Janus tyrosine kinase 2/signal transducer and activator of transcription 3 | phosphatidylinositol 3-kinase/Akt | A549 cells | cardiotoxin III | epidermal growth factor receptor | SURVIVAL | APOPTOSIS | CYTOTOXIN | PHYSIOLOGY | CANCER CELLS | MCL-1 | STATS | signal transducer and activator of transcription 3 | MECHANISMS | DEATH | Akt | Janus tyrosine kinase 2 | INHIBITION | BCL-2 PROTEIN FAMILY | PHARMACOLOGY & PHARMACY | phosphatidylinositol 3-kinase | Membrane Potentials - drug effects | Cell Survival - drug effects | Phosphorylation | Apoptosis - drug effects | Cytochromes c - metabolism | Humans | Cytosol - drug effects | Cobra Cardiotoxin Proteins - toxicity | Mitochondria - metabolism | Mitochondria - drug effects | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Blotting, Western | Mitochondrial Membranes - drug effects | Proto-Oncogene Proteins c-bcl-2 - metabolism | Caspases - metabolism | Flow Cytometry | Signal Transduction - drug effects | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cytosol - metabolism | STAT3 Transcription Factor - antagonists & inhibitors | Janus Kinase 2 - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Cytochrome c | Tyrosine | Medical colleges | Epidermal growth factor | Phenols | Mutual fund industry | Phospholipids | Index Medicus
Journal Article
Journal Article